tirz

Tirzepatide is a premier, dual-agonist synthetic peptide designed for cutting-edge metabolic research. Targeting both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, this “twincretin” analog is an essential tool for investigating weight regulation, glycemic control, and insulin sensitivity. Each vial is vacuum-sealed and guaranteed at 99% purity, ensuring the highest level of accuracy for in vitro and in vivo longitudinal studies.